Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
3.

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

ZuWallack AR, ZuWallack RL.

Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051.

PMID:
15264997
4.

Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.

Keating GM.

Drugs. 2012 Jan 22;72(2):273-300. doi: 10.2165/11208620-000000000-00000. Review.

PMID:
22217233
5.

Inhaled tiotropium for stable chronic obstructive pulmonary disease.

Barr RG, Bourbeau J, Camargo CA, Ram FS.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002876. Review.

PMID:
15846642
6.
7.

Tiotropium HandiHaler in the treatment of COPD: a safety review.

Kesten S, Celli B, Decramer M, Leimer I, Tashkin D.

Int J Chron Obstruct Pulmon Dis. 2009;4:397-409. Epub 2009 Nov 29. Review.

8.

Tiotropium versus placebo for chronic obstructive pulmonary disease.

Karner C, Chong J, Poole P.

Cochrane Database Syst Rev. 2014 Jul 21;7:CD009285. doi: 10.1002/14651858.CD009285.pub3. Review.

PMID:
25046211
9.

Tiotropium versus placebo for chronic obstructive pulmonary disease.

Karner C, Chong J, Poole P.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD009285. doi: 10.1002/14651858.CD009285.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD009285.

PMID:
22786525
10.

Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.

Tashkin DP.

Expert Rev Respir Med. 2010 Jun;4(3):279-89. doi: 10.1586/ers.10.23. Review.

PMID:
20524910
11.
12.

Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.

Joos GF, Brusselle G, Derom E, Pauwels R.

Int J Clin Pract. 2003 Dec;57(10):906-9. Review.

PMID:
14712894
13.

Tiotropium: an inhaled anticholinergic for chronic obstructive pulmonary disease.

Olin JL.

Am J Health Syst Pharm. 2005 Jun 15;62(12):1263-9. Review.

PMID:
15947126
14.

Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.

Panning CA, DeBisschop M.

Pharmacotherapy. 2003 Feb;23(2):183-9. Review.

PMID:
12587807
15.

Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.

Kerwin EM, Williams J.

Ther Adv Respir Dis. 2013 Feb;7(1):25-37. doi: 10.1177/1753465812470018. Epub 2013 Jan 7. Review.

PMID:
23296242
16.

The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.

Saberi F, O'Donnell DE.

Treat Respir Med. 2005;4(4):275-81. Review.

PMID:
16086600
17.

Long-term bronchodilator inhaled therapy in COPD: the role of tiotropium bromidum.

Antoniu SA.

Rev Recent Clin Trials. 2009 May;4(2):89-98. Review.

PMID:
19463105
18.

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

Oba Y, Zaza T, Thameem DM.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):575-84. Review.

19.

Role of tiotropium in the treatment of COPD.

Rice KL, Kunisaki KM, Niewoehner DE.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):95-105. Review.

20.

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Hilleman DE, Malesker MA, Morrow LE, Schuller D.

Int J Chron Obstruct Pulmon Dis. 2009;4:253-63. Epub 2009 Jul 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk